Plain-English translation of NCT07499440 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our PTSD research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a research study testing whether — a new medication containing two active ingredients — is safe and effective for treating post-traumatic stress disorder (PTSD) in adults. About 200 people will take part, split into two groups: some will receive the medication, and others will receive a placebo (a pill with no active ingredients). The medication will be tested over 12 weeks to see if it helps reduce PTSD symptoms.
Many people with PTSD struggle to find treatments that work well for them. Researchers believe this new combination medication might help reduce symptoms in ways that current treatments do not, which is why they're studying it carefully in this clinical trial.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll come to a research clinic multiple times over 12 weeks. At each visit, you'll take the medication (or placebo) as directed, answer questions about how you're feeling, and have basic health checks like blood pressure and heart rhythm monitoring. After your 12 weeks are complete, you'll have one more follow-up visit about a week later to make sure you're doing well. The research team will watch carefully for any side effects or changes in your health throughout the entire study.
AI-generated summary from trial data · Sep 17, 2026 · Not medical advice
Australia